The researchers hope to design a therapeuticvaccine, slow HIV disease process, so that failure of B-cell secretion restore the ability of high-quality antibodies.
研究者希望能设计一种治疗性的疫苗，减缓HIV的疾病进程，使失效的B细胞恢复分泌高质量抗体的能力。
2
The aim of this study was to express a fusion protein of HBV preS1 Ag(1-42) and HBcAg(1-144) and analyze its immunogenicity for further study of HBV therapeuticvaccine.
The therapeuticvaccine candidate targeted the stimulation of CD4(+) and CD8(+) T-cell responses and the induction of pro-inflammatory cytokines capable of controlling viral replication.